Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition used for treating swine mastitis and preparation method thereof

A mastitis and composition technology, applied in the field of pharmaceutical composition for treating porcine mastitis and its preparation, can solve the problems of affecting people's health, affecting the treatment effect, and high treatment cost, and achieves simple production, unobstructed qi and blood, and improved The effect of curative effect

Inactive Publication Date: 2011-02-16
TIANJIN SHENGJI GRP CO LTD
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the drugs commonly used in the prevention and treatment of porcine mastitis mainly include antibiotics such as macrolides, tetracyclines, lincosamides, and fluoroquinolones. Affect further treatment effects, especially antibiotics will remain in pigs, which will affect people's health after eating
Therefore, the current use of antibiotics has been limited in livestock and poultry production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] A pharmaceutical composition for the treatment of porcine mastitis, consisting of the following medicines, each part is calculated as 10g, and 120g of honeysuckle, 120g of forsythia, 120g of dandelion, 120g of Viola chinensis, 110g of Anemarrhena, Cortex Phellodendri 110g, 110g Akebia, 110g rhubarb, and 110g licorice were pulverized and sieved to make the particle size reach 60 mesh, mixed evenly and divided into packages to obtain the finished product.

Embodiment 2

[0030] A pharmaceutical composition for the treatment of porcine mastitis, consisting of the following medicines, each part is calculated as 10g, and 140g of honeysuckle, 130g of forsythia, 150g of dandelion, 160g of Viola chinensis, 70g of anemarrhena, Cortex Phellodendri 80g, 90g of Akebia, 100g of rhubarb and 70g of licorice were pulverized and sieved to make the particle size reach 100 mesh, mixed evenly and packed separately to obtain the finished product.

Embodiment 3

[0032] A pharmaceutical composition for the treatment of porcine mastitis, consisting of the following medicines, each part is calculated as 10g, and honeysuckle 160g, forsythia 150g, dandelion 130g, Viola chinensis 130g, Anemarrhena 90g, Phellodendron cortex are weighed in parts by weight 110g, 70g of Akebia, 70g of rhubarb, and 90g of licorice were crushed and sieved to make the particle size reach 150 mesh, mixed evenly and packaged separately to obtain the finished product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Granularityaaaaaaaaaa
Login to View More

Abstract

The invention relates to a medicinal composition used for treating swine mastitis and a preparation method thereof. The medicinal composition is characterized by comprising the following components in part by weight: 12 to 16 parts of honeysuckle, 12 to 16 parts of fructus forsythiae, 12 to 16 parts of dandelion, 12 to 16 parts of Chinese violet, 7 to 11 parts of rhizoma anemarrhenae, 7 to 11 parts of corktree, 7 to 11 parts of akebiaquinata, 7 to 11 parts of Chinese rhubarb and 7 to 11 parts of liquorice. The preparation method comprises the following steps of: weighing the medicaments serving as raw materials in part by weight; crushing and screening the medicaments until the grain size reaches 60 to 200 meshes; and obtaining a finished product by packaging. The medicinal composition has the advantages that: bacterial infection is a main reason to cause the swine mastitis and the swine mastitis is often accompanied by different degrees of inflammation and stagnation, so the formula can clear heat, release toxin, diminish inflammation, eliminate swelling, regulate vital energy, activate channels and collaterals, smooth qi and blood, stop pain and eliminate the swelling, remove stasis and soften hardness. The medicinal composition has an outstanding curative effect, a high curative effect, no medicament residue and no side or toxic effect, and plays roles of the Chinese medicaments in resisting bacteria, diminishing inflammation, activating blood and dissolving stasis in a disease treating process.

Description

technical field [0001] The invention belongs to traditional Chinese medicine for pigs, in particular to a pharmaceutical composition for treating swine mastitis and a preparation method thereof. Background technique [0002] Porcine mastitis (clinical bovine mastitis), also known as mastitis, is one of the most common, difficult and costly diseases of pigs. The disease is mainly a mammary gland disease caused by a variety of non-specific pathogenic microorganisms, showing obvious clinical symptoms in pig udder and milk, but among many pathogens, bacterial infection is the main cause of porcine mastitis. The occurrence of this disease will reduce the milk production of pigs, and in severe cases, it will cause blind teats and affect the feeding of piglets. There is still no effective radical cure and effective vaccine for this at present, and only antibacterial drugs are used to prevent and treat this disease. At present, the drugs commonly used in the prevention and treatme...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/16A61P15/14A61K36/8964
Inventor 赵会芹
Owner TIANJIN SHENGJI GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products